Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lipomize is a biotechnology company based in Argentina that specializes in the development and manufacturing of liposomal drug delivery systems. The company utilizes advanced nanotechnology to encapsulate active ingredients, enhancing their stability, bioavailability, and targeted delivery for the pharmaceutical, cosmetic, and nutraceutical industries. Lipomize operates primarily as a contract development and manufacturing organization (CDMO), providing custom formulation services and a portfolio of proprietary liposomal products. Their expertise spans from laboratory-scale research to industrial-scale production, focusing on improving the efficacy of vitamins, supplements, and therapeutic compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lipomize.